We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$102B
AUM Growth
+$1.43B
(+1.4%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
287
New
14
Increased
80
Reduced
134
Closed
11
Avg Time Held
2.7
years
Top 10 Avg Time Held
3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$518M |
| 2 |
AstraZeneca
AZN
|
+$246M |
| 3 |
Alkermes
ALKS
|
+$172M |
| 4 |
Whirlpool
WHR
|
+$94.4M |
| 5 |
Eli Lilly
LLY
|
+$78.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QGENF
QIAGEN NV
QGENF
|
+$534M |
| 2 |
Charles Schwab
SCHW
|
+$265M |
| 3 |
Amgen
AMGN
|
+$235M |
| 4 |
NVIDIA
NVDA
|
+$233M |
| 5 |
Microsoft
MSFT
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.82% |
| 2 | Healthcare | 22.95% |
| 3 | Industrials | 16.78% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Financials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
DELISTED
Praxair Inc
PX
| $182M | 0.18% |
1,549,470
-13,200
| -0.8% | -$1.57M |
2013 Q2
14 quarters
|
|
102
CSX Corp
CSX
$90.2B
| $178M | 0.18% |
14,872,800
-78,750
| -0.5% | -$883K |
2013 Q2
14 quarters
|
|
103
Comscore
SCOR
$61.2M
| $178M | 0.17% |
281,417
+3,052
| +1% | +$1.84M |
2013 Q2
14 quarters
|
|
|
NUAN
104
DELISTED
Nuance Communications, Inc.
NUAN
| $176M | 0.17% |
13,664,053
-105,509
| -0.8% | -$1.36M |
2013 Q2
14 quarters
|
|
105
Northern Trust
NTRS
$30.3B
| $175M | 0.17% |
1,961,400
| – | – |
2016 Q1
3 quarters
|
|
106
Merck
MRK
$358B
| $174M | 0.17% |
3,101,137
-5,449
| -0.2% | -$319K |
2014 Q4
8 quarters
|
|
107
Boeing
BA
$149B
| $165M | 0.16% |
1,058,025
-17,225
| -2% | -$2.52M |
2013 Q2
14 quarters
|
|
|
BBBY
108
DELISTED
Bed Bath & Beyond Inc
BBBY
| $164M | 0.16% |
4,047,356
-7,900
| -0.2% | -$343K |
2013 Q2
14 quarters
|
|
109
RTX Corp
RTX
$252B
| $154M | 0.15% |
2,236,200
| – | – |
2013 Q4
12 quarters
|
|
110
Xencor
XNCR
$1.78B
| $152M | 0.15% |
5,768,822
+571,227
| +11% | +$13.7M |
2013 Q4
12 quarters
|
|
|
VMW
111
DELISTED
VMware, Inc
VMW
| $145M | 0.14% |
1,841,812
-5,200
| -0.3% | -$404K |
2013 Q2
14 quarters
|
|
112
MarketAxess Holdings
MKTX
$5.79B
| $141M | 0.14% |
959,720
-43,700
| -4% | -$6.94M |
2013 Q2
14 quarters
|
|
113
Las Vegas Sands
LVS
$24.8B
| $134M | 0.13% |
2,502,481
| – | – |
2013 Q2
14 quarters
|
|
114
Rockwell Automation
ROK
$46.9B
| $127M | 0.12% |
944,610
-250
| -0% | -$31.9K |
2013 Q2
14 quarters
|
|
|
ABAX
115
DELISTED
Abaxis Inc
ABAX
| $121M | 0.12% |
2,289,200
-33,800
| -1% | -$1.74M |
2013 Q4
12 quarters
|
|
116
Rambus
RMBS
$10.1B
| $120M | 0.12% |
8,708,272
-202,200
| -2% | -$2.62M |
2013 Q2
14 quarters
|
|
117
Curtiss-Wright
CW
$18.5B
| $119M | 0.12% |
1,212,900
-109,500
| -8% | -$10.4M |
2013 Q3
13 quarters
|
|
118
Apple
AAPL
$4.99T
| $118M | 0.12% |
4,086,800
| – | – |
2013 Q2
14 quarters
|
|
|
119
Whirlpool
WHR
$1.83B
| $118M | 0.12% |
649,022
+569,922
| +721% | +$94.4M |
2013 Q2
14 quarters
|
|
120
DuPont de Nemours
DD
$17.8B
| $110M | 0.11% |
759,238
+138,771
| +22% | +$19.3M |
2013 Q2
14 quarters
|
|
121
DELISTED
Electronic Arts
EA
| $109M | 0.11% |
1,389,100
-24,750
| -2% | -$1.99M |
2013 Q2
14 quarters
|
|
122
IDEX
IEX
$17.4B
| $108M | 0.11% |
1,196,210
-8,010
| -0.7% | -$725K |
2013 Q2
14 quarters
|
|
123
Descartes Systems
DSGX
$7.58B
| $105M | 0.1% |
4,883,890
-6,600
| -0.1% | -$140K |
2013 Q2
14 quarters
|
|
124
Pentair
PNR
$8.53B
| $97.3M | 0.1% |
2,582,671
-10,274
| -0.4% | -$401K |
2013 Q2
14 quarters
|
|
125
Jabil
JBL
$30.1B
| $95.1M | 0.09% |
4,018,800
+34,325
| +0.9% | +$748K |
2013 Q2
14 quarters
|
|
Similar funds
Primecap Management's Q4 2016 Portfolio in Review
As of Q4 2016, Primecap Management held 287 positions worth $102B, up 1.4% from $100B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management's Q4 2016 filing shows 14 new, 80 increased, 134 reduced and 11 closed positions. Its largest new stake was Qiagen: 17,384,319 shares worth $536M. The largest sale was QIAGEN NV, an estimated $534M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2016 buy was Qiagen: 17,384,319 shares worth $536M.
- Primecap Management added most to AstraZeneca in Q4 2016, an estimated $246M increase.
- Primecap Management's biggest Q4 2016 reduction was Charles Schwab, cutting an estimated $265M.
- Primecap Management fully exited QIAGEN NV in Q4 2016, selling an estimated $534M.
- Primecap Management's ten largest holdings make up 33% of its $102B portfolio in Q4 2016.
- Primecap Management opened 14 new positions and closed 11 in Q4 2016.
- Primecap Management's portfolio value rose 1.4% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q4 2016, filed 13 Feb 2017.